FR350M - New antibiotic lankavamycin usable in therapy. - Google Patents

New antibiotic lankavamycin usable in therapy.

Info

Publication number
FR350M
FR350M FR836983A FR836983A FR350M FR 350 M FR350 M FR 350M FR 836983 A FR836983 A FR 836983A FR 836983 A FR836983 A FR 836983A FR 350 M FR350 M FR 350M
Authority
FR
France
Prior art keywords
lankavamycin
usable
therapy
new antibiotic
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR836983A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH7340059A external-priority patent/CH374147A/en
Priority claimed from FR827673A external-priority patent/FR1295910A/en
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR836983A priority Critical patent/FR350M/en
Application granted granted Critical
Publication of FR350M publication Critical patent/FR350M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR836983A 1959-05-20 1960-08-29 New antibiotic lankavamycin usable in therapy. Active FR350M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR836983A FR350M (en) 1959-05-20 1960-08-29 New antibiotic lankavamycin usable in therapy.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH7340059A CH374147A (en) 1959-05-20 1959-05-20 Process for the production of a new antibiotic
CH127660 1960-02-05
FR827673A FR1295910A (en) 1960-05-19 1960-05-19 Process for preparing two novel antibiotics called <<lankavamycin>> and <<lankavacidin>>, from a strain of streptomyces
FR836983A FR350M (en) 1959-05-20 1960-08-29 New antibiotic lankavamycin usable in therapy.

Publications (1)

Publication Number Publication Date
FR350M true FR350M (en) 1961-03-27

Family

ID=25687181

Family Applications (1)

Application Number Title Priority Date Filing Date
FR836983A Active FR350M (en) 1959-05-20 1960-08-29 New antibiotic lankavamycin usable in therapy.

Country Status (2)

Country Link
FR (1) FR350M (en)
GB (1) GB949473A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011080739A2 (en) * 2009-12-29 2011-07-07 Yeda Research And Development Co. Ltd. Synergistic antibiotic combinations and derivatives

Also Published As

Publication number Publication date
GB949473A (en) 1964-02-12

Similar Documents

Publication Publication Date Title
FR369M (en) Halogenotetracyclines.
FR308M (en) New pyridyl-ethyl-guanidine usable in therapy.
BE596003A (en) Amino-hydroxy-nitriles.
FR302M (en) New m-butoxy-phenoxy-ethylamine usable in therapy.
FR350M (en) New antibiotic lankavamycin usable in therapy.
FR1898M (en) New substance usable in therapy.
FR351M (en) New antibiotic lankavacidin usable in therapy.
FR352M (en) New ferrimycin antibiotic usable in therapy.
OA01426A (en) Advanced synchro-machines.
DK103424C (en) Høvender.
DK120015B (en) Fluidistor.
BE595070A (en) Plansichter.
FR353M (en) New quinoline usable in therapy.
FR309M (en) New piperazino-ethyl-guanidine usable in therapy.
FR1233212A (en) Cystoscope usable in pediatrics
DK95557C (en) Glashus.
FR222M (en) New 2,5-bis-ethylene-imino-3,6-bis-acylamino-p-benzoquinone usable in therapy.
FR348M (en) New 3,5,6-substituted glucofuranoside usable in therapy.
FR1029M (en) New 17α-isobutyl-androstane-3β, 17β-diol usable in therapy.
BE596272A (en) New substance usable in therapy.
FR303M (en) New guanidine usable in therapy.
FR3174M (en) New δ-3β17β-dihydroxy-7α17α-dimethyl-19-nor-androstene usable in therapy.
FR163M (en) New phenoxy-ethylamine usable in therapy.
BE583857A (en) Opacifying agent usable in radiology.
FR269M (en) New antibiotic substances.